OneMedNet Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ONMD | ONE.AX | ALINS.PA | NURS.V | ALC.AX | CCLD | |
|---|---|---|---|---|---|---|
| Market cap | 26.44M | 105.63M | 10.76M | 150.82M | 155.23M | 76.49M |
| P/E (TTM) | — | — | — | 21.6 | — | 30.0 |
| Forward P/E | — | -11.6 | -4.1 | 5.9 | 34.6 | 4.0 |
| Price/book | -7.5 | 9.4 | -9.3 | 3.8 | 1.7 | 4.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −75.94% | −38.46% | −21.15% | −38.74% | +15.38% | −41.69% |
| Today | +4.13% | 0.00% | −0.49% | −6.95% | +9.52% | +4.65% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 20 min.
Latest news
All ONMD news ›OneMedNet secures mid six-figure re-order for AI radiology data, boosting foundation model training.
OneMedNet Corporation received a mid six-figure re-order from a foundation model company developing advanced AI radiology models, expanding their multi-modal imaging data agreement. This repeat order highlights the demand for OneMedNet's…
Analyzing OneMedNet (ONMD) and The Competition
Posted by Defense World Staff on Oct 31st, 2026 OneMedNet (NASDAQ:ONMD – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it compare to its peers? We will compare OneMedNet to similar…
Price to book forward of OneMedNet Corp – NASDAQ:ONMDW
TradingView Price to book forward of OneMedNet Corp
OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Loss OneMedNet (ONMD) signed its 12th channel partner agreement, adding a global pharmaceutical…
OneMedNet Expands iRWD Platform With Leading Hospital System, Plans Up to 12 More Hospital Additions
OneMedNet Corporation has partnered with a leading hospital system to enhance its iRWD™ platform and network. RWD supports AI innovation and generates Real-World Evidence for regulatory submissions and clinical research across life…
OneMedNet director Kosasa buys $750K in shares
OneMedNet Corp (ONMD) curates regulatory-grade, AI-ready Real-World Data via its iRWD™ platform, serving life sciences, medical device, and healthcare AI organizations. OneMedNet director Kosasa buys $750K in shares The subscription…
OneMedNet’s Jeffrey Yu buys $250K in common shares
OneMedNet Corp (ONMD) curates regulatory-grade, AI-ready Real-World Data via its iRWD™ platform, serving life sciences, medical device, and healthcare AI organizations. OneMedNet’s Jeffrey Yu buys $250K in common shares The $250,000…
OneMedNet regains Nasdaq $1.00 minimum bid price compliance
TradingView OneMedNet regains Nasdaq $1.00 minimum bid price compliance OneMedNet regained compliance with Nasdaq's $1.00 minimum bid price requirement after a 10-business-day stretch of closing prices at or above $1.00. - Nasdaq notified
OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
Real-world evidence is information gathered from everyday sources like patient records, insurance claims, or everyday experiences, rather than controlled experiments or clinical trials. It helps investors understand how products or…
OneMedNet CEO Aaron Green sells shares to cover taxes
OneMedNet Corp (ONMD) curates regulatory-grade, AI-ready Real-World Data via its iRWD™ platform, serving life sciences, medical device, and healthcare AI organizations. OneMedNet CEO Aaron Green sells shares to cover taxes The chief…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net7
- globenewswire.com3
- tradingview.com2
- defenseworld.net1
- natlawreview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.